Andrew Retter insider trades

Open-market stock purchases and sales by Andrew Retter, Chief Medical Officer at Volitionrx Ltd, from SEC Form 4 filings since May 23, 2024.

Recent trades

DateStockTradeValue
Nov 1, 2025VNRX Volitionrx LtdSold (not open market)$2K

Companies traded

  • VNRX Volitionrx Ltd: other filings, last Nov 1, 2025
  • VRNX Volitionrx Ltd: other filings, last May 1, 2025

Get free alerts when Andrew Retter files a new trade →